Hexachlorophene

Hexachlorophene

SCHEMBL2806744

Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl.[KH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

fabI

The experimentally established mechanism targets of Hexachlorophene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 9/20 0.95
HPGD P15428 7/20 0.95
TSHR P16473 7/20 0.95
CYP3A4 P08684 5/20 0.95
HIF1A Q16665 4/20 0.95
CYP2C19 P33261 3/20 0.95
SMN1; SMN2 Q16637 3/20 0.95
MAPK1 P28482 2/20 0.95
RECQL P46063 2/20 0.95
HSP90AA1 P07900 2/20 0.95
THRB P10828 2/20 0.95
CYP1A2 P05177 2/20 0.95
ALOX15 P16050 2/20 0.95
ALOX12 P18054 2/20 0.95
HSPA5 P11021 2/20 0.95
MEN1 O00255 1/20 0.95
NPC1 O15118 1/20 0.95
USP2 O75604 1/20 0.95
EGFR P00533 1/20 0.95
LMNA P02545 1/20 0.95

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexachlorophene SCHEMBL29352805 0.98 HSD17B10 (1.00) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL15579 0.98 HSD17B10 (1.00) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL2810158 0.95 HSD17B10 (0.95) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL16339207 0.95 HSD17B10 (0.95) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL11693520 0.95 HSD17B10 (0.95) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL19689282 0.95 HSD17B10 (0.95) HSD17B10HPGDTSHRCYP3A4HIF1A
Hexachlorophene SCHEMBL3468532 0.95 HSD17B10 (0.95) HSD17B10HPGDTSHRCYP3A4HIF1A
SCHEMBL14644982 0.86 SIRT1 (1.00) HSD17B10HPGDTSHRCYP3A4HIF1A
SCHEMBL13287028 0.86 SIRT1 (0.86) HSD17B10HPGDTSHRCYP3A4HIF1A
SCHEMBL8822888 0.85 HSD17B10 (0.76) HSD17B10HPGDTSHRCYP3A4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250024837-A1 PESTICIDE SYSTEM BANISH, MICHELE 2025-01-23 US disclosed
US-20240074434-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2024-03-07 US disclosed
US-20240065262-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2024-02-29 US disclosed
WO-2023154183-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY (US) 2023-08-17 WO disclosed
US-20230172194-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2023-06-08 US disclosed
US-20220272987-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY H (US) 2022-09-01 US disclosed
EP-2207416-B1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM IMERYS FILTRATION MINERALS INC (US) 2018-11-07 EP disclosed
US-20100239679-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2010-09-23 US disclosed
EP-2207416-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM World Minerals, Inc. (US) 2010-07-21 EP disclosed
WO-2009045941-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250024837-A1 PESTICIDE SYSTEM ACHE, PFAS, FPGS HSD17B10 1533/4885HPGD 2359/4885TSHR 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.